ICMR to conduct trials of indigenously developed Zika vaccine

The Indian Council of Medical Research will soon undertake Phase II testing of the indigenously developed vaccine against Zika virus, cases of which have been reported in Madhya Pradesh, Rajasthan and Gujarat, reported The Economic Times.

Bharat Biotech has developed a vaccine it claims will provide protection against infection caused by an Asian Zika virus strain, as well as by the African Zika strain, an official said.

"The company had developed the vaccine around two years ago. At that time we did not have an outbreak of Zika in India as it was only restricted to Latin America," the official noted.

He added that the process for regulatory approvals to carry out the trial will be initiated soon.

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.